While triple negative breast cancer most commonly exhibit high infiltrations of these tumor-infiltrating lymphocytes (TILs), ER+ patients generally have lower TIL infiltration levels [58], making infiltration levels difficult to be accurately inferred by immune deconvolution methods from gene expression data. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.